They are not the topic. RDGL is. They cite facts that raise serious issues/concerns regarding RDG'Ls serial failures getting Radiogel to market. Since you can't refute the issues raised, you go off topic with ad hominem inquiries and implied accusations.
Likewise with responses "the science works" uncontrolled IsoPet application examples. FDA has made very clear they need controlled animal data to consider Radiogel for human trials. Uncontrolled IsoPet anecdotes aren't data. Moreover, IsoPet has no plausible path to profitability. It's just another irrelevant distraction from the only thing that matters here.
Then with the India human trials now on hold, in only case (1 out of 10) we have any detail on, MK revealed the treatment failed to kill the tumor. And that was supposed to sway FDA after they were so emphatic dosage and application techniques be worked out before human trials? There seems to be no bounds to MK's incompetence.